Tocagen

Biopharma, Biotechnology, Genetics, Therapeutics
Founded in 2007-01-01
San Diego, California, United States
http://www.tocagen.com
For Profit

About Tocagen

Tocagen is a biopharmaceutical company, engages in the discovery, development, and commercialization of products for the treatment of cancer. It develops gene therapy products for treating primary tumors and metastatic diseases. The company's products comprise Prodrug Activator product candidates for treating glioblastoma multiforme; and immunotherapeutic product candidates for treating metastatic malignant melanoma. Tocagen was founded in 2007 and is based in San Diego, California.

Company Metrics

  • Employees: 101-250
  • Monthly Visits: None
  • Tech Stack: 21 active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: 168611970 USD
  • Last Funding: 72500000 USD (Post-IPO Equity)
  • Funding Status: M&A

Technology Stack

Tocagen actively uses 21 products in their tech stack.

Market Presence

Industries: Biopharma, Biotechnology, Genetics, Therapeutics

Headquarters: San Diego, California, United States